|
October 1, 2008 - National Cancer Institute of the United States Expands Use of AIM's E-Path Software The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute (NCI) and Artificial Intelligence In Medicine Inc. (AIM) are pleased to announce a five year extension of their original 2003 agreement to install AIM's E-Path software in 207 SEER Registries and their major reporting laboratories. This extension will add 40 more hospitals to the program, as well as provide additional software for cancer research and for enhancing the security of patient records. This contract began October 1, 2008. The SEER Program is an authoritative source of information on cancer incidence and survival in the United States. It currently collects and publishes cancer incidence and survival data from 14 population-based cancer registries and four supplemental registries covering approximately 26 percent of the US population, and has information on more than 3.8 million cancer cases. SEER purchased AIM's software to assist in coping with the steadily increasing demands for detailed, accurate cancer data.
In business since 1983, AIM is a Canadian software engineering firm with a firm focus on cancer informatics. For further information please contact: Carol L. Kosary
Victor Brunka |
||
|
Copyright © AIM Inc.
|
||